Douglas Boothe Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas Boothe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas Boothe. Douglas Boothe is a President and CEO in AKORN INC ($AKRN.PK) and a President, Generics Division in IMPAX LABORATORIES INC ($IPXL) and a EVP & GM Perrigo Pharma in PERRIGO CO ($PRGO) and a EVP & GM Perrigo Pharma in PERRIGO Co plc ($PRGO).
Address: C/O PERRIGO COMPANY 515 EASTERN AVENUE ALLEGAN 49010 MI
Companies in which Douglas Boothe is an Insider
AKORN INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas Boothe: President and CEO
Holdings: 466,261 shares
Latest Transaction: Jan 10 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Impax Laboratories, LLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas Boothe: President, Generics Division
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 08 2018
$IPXL Market Capitalization: $952.26M
$IPXL Previous Close: $13.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PERRIGO CO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas Boothe: EVP & GM Perrigo Pharma
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 19 2013
$PRGO Market Capitalization: $11.17B
$PRGO Previous Close: $77.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PERRIGO Co plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas Boothe: EVP & GM Perrigo Pharma
Holdings: 803 shares
Current Value: $62,698
Latest Transaction: Mar 01 2016
$PRGO Market Capitalization: $11.15B
$PRGO Previous Close: $78.08
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Douglas Boothe
Sentiment: All, AKRN.PK, IPXL, PRGO, PRGO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10 2020 | AKRN.PK | AKORN INC | Boothe Douglas | President and CEO | Payment of Exercise | F | 1.25 | 41,353 | 51,691 | 466,261 | 507.6 K to 466.3 K (-8.15 %) |
| Jan 08 2019 | AKRN.PK | AKORN INC | Boothe Douglas | President and CEO | Option Exercise | A | 0.00 | 253,807 | 0 | 253,807 | |
| Jan 08 2019 | AKRN.PK | AKORN INC | Boothe Douglas | President and CEO | Option Exercise | A | 3.94 | 405,938 | 1,599,396 | 405,938 | |
| Jan 08 2019 | AKRN.PK | AKORN INC | Boothe Douglas | President and CEO | Grant | A | 0.00 | 507,614 | 0 | 507,614 | 0 to 507.6 K |
| May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Option Exercise | D | 9.35 | 56,232 | 525,769 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Option Exercise | D | 24.42 | 50,500 | 1,233,210 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Sell | D | 0.00 | 41,756 | 0 | 0 | 41.8 K to 0 (-100.00 %) |